Intensity Therapeutics Inc. (NASDAQ: INTS)
$4.92
N/A ( 0% ) 3.4K
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.
Market Data
Open
$4.92
Previous close
$4.92
Volume
3.4K
Market cap
$67.88M
Day range
$4.70 - $5.17
52 week range
$2.01 - $11.44
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 03, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
def | Proxies and info statements | 5 | Jun 04, 2024 |
ars | Annual reports | 1 | Jun 04, 2024 |
8-k | 8K-related | 13 | May 24, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
3 | Insider transactions | 4 | May 15, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
8-k | 8K-related | 13 | May 10, 2024 |
10-q | Quarterly Reports | 62 | May 09, 2024 |